en

PRODUCT DETAIL

Ditustat Neo

Code 1448E
MA number 36/0188/22-S
Product Form: sol por 1x100 ml/600 mg (fľ.skl.jantár. + odmerka PP)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 36 - ANTITUSSICA
ATC:
R RESPIRATORY SYSTEM
R05 COUGH AND COLD PREPARATIONS
R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS
R05DB Other cough suppressants
R05DB27 Levodropropizine
Shelf life: 24
Container: amber glass bottle
Route of admin.: Oral use
Prescription Status: Medicinal product not subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 11.07.2022
Validity: 11.07.2027
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric contraindication: Yes
Pediatric warnings: Yes
PIL: PIL_Ditustat Neo_07_2022.pdf  
SPC: SPC_Ditustat Neo_07_2022.pdf  
Safety feature Unknown
Data update: 14.07.2022
eu-flag.png sk-flag.png